Cassava Sciences reported $-44220000 in Pre-Tax Profit for its fiscal quarter ending in June of 2025.


Pre Tax Profit Change Date
Abbott USD 2.15B 372M Jun/2025
Amgen USD 1.57B 405M Jun/2025
Biogen USD 744M 432.8M Jun/2025
Cassava Sciences USD -44220000 16.62M Jun/2025
Eisai JPY 22.4B 22.43B Jun/2025
Eli Lilly USD 6.78B 3.32B Jun/2025
Geron USD -16375000 3.46M Jun/2025
J&J USD 13.63B 8.21B Mar/2025
Merck USD 6.77B 864M Jun/2025
Novartis USD 4.53B 124M Jun/2025
Pfizer USD 3.04B 259M Jun/2025
Roche Holding CHF 1.78B 2.33B Dec/2024